Genetic Technologies Ltd.

(GNTLF)

By |

Profile

Genetic Technologies Ltd is an Australia-based molecular diagnostics company which offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States.

Contact Information

Website: www.gtglabs.com
Main Phone: +61 384127000
Address: 60-66 Hanover Street
Address 2: P.O. Box 115, Fitzroy
State: VIC
City / Town: Melbourne
Country: AU
Postal Code: 3065

Issuer Information

Exchange: GREY
CEO: Jerzy Muchnicki
Employees: 13
NAICS: Biological Produ

Equities News

Profile

Genetic Technologies Ltd is an Australia-based molecular diagnostics company which offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States.

Contact Information

Website: www.gtglabs.com
Main Phone: +61 384127000
Address: 60-66 Hanover Street
Address 2: P.O. Box 115, Fitzroy
State: VIC
City / Town: Melbourne
Country: AU
Postal Code: 3065

Issuer Information

Exchange: GREY
CEO: Jerzy Muchnicki
Employees: 13
NAICS: Biological Produ

Equities News

$ 0.001 $ 0. (0.00%)
Last Price 0.001 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 0.001
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap 8.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 8,261,726,743.00 EPS (TTM) N/A PE Ratio N/A Exchange Greys